Indaptus Therapeutics INDP Stock
Indaptus Therapeutics Price Chart
Indaptus Therapeutics INDP Financial and Trading Overview
| Indaptus Therapeutics stock price | 2.77 USD |
| Previous Close | 2.56 USD |
| Open | 2.69 USD |
| Bid | 2.74 USD x 100 |
| Ask | 3.15 USD x 100 |
| Day's Range | 2.46 - 2.94 USD |
| 52 Week Range | 0.92 - 8.57 USD |
| Volume | 1.79M USD |
| Avg. Volume | 657.36K USD |
| Market Cap | 369.08M USD |
| Beta (5Y Monthly) | 1.171 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.56 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
INDP Valuation Measures
| Enterprise Value | 357.53M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.9928057 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 32.588234 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Indaptus Therapeutics Stock Price History
| Beta (5Y Monthly) | 1.171 |
| 52-Week Change | -0.77% |
| S&P500 52-Week Change | 15.30% |
| 52 Week High | 8.57 USD |
| 52 Week Low | 0.92 USD |
| 50-Day Moving Average | 1.78 USD |
| 200-Day Moving Average | 2.19 USD |
INDP Share Statistics
| Avg. Volume (3 month) | 657.36K USD |
| Avg. Daily Volume (10-Days) | 1.87M USD |
| Shares Outstanding | 133.24M |
| Float | 23.36M |
| Short Ratio | 0.27 |
| % Held by Insiders | 82.44% |
| % Held by Institutions | 0.30% |
| Shares Short | 212.36K |
| Short % of Float | 0.16% |
| Short % of Shares Outstanding | 0.16% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:28 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -98.080% |
| Return on Equity (ttm) | -318.036% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -15423500 USD |
| Diluted EPS (ttm) | -3.56 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 11.55M USD |
| Total Cash Per Share (mrq) | 0.09 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 19.479 |
| Book Value Per Share (mrq) | 0.085 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -14695567 USD |
| Levered Free Cash Flow (ttm) | -9672618 USD |
Profile of Indaptus Therapeutics
| Country | United States |
| State | NY |
| City | New York |
| Address | Three Columbus Circle |
| ZIP | 10019 |
| Phone | 646 427 2727 |
| Website | https://indaptusrx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 5 |
Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as for the treatment of advanced solid tumors. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York.
Q&A For Indaptus Therapeutics Stock
What is a current INDP stock price?
Indaptus Therapeutics INDP stock price today per share is 2.77 USD.
How to purchase Indaptus Therapeutics stock?
You can buy INDP shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Indaptus Therapeutics?
The stock symbol or ticker of Indaptus Therapeutics is INDP.
Which industry does the Indaptus Therapeutics company belong to?
The Indaptus Therapeutics industry is Biotechnology.
How many shares does Indaptus Therapeutics have in circulation?
The max supply of Indaptus Therapeutics shares is 133.24M.
What is Indaptus Therapeutics Price to Earnings Ratio (PE Ratio)?
Indaptus Therapeutics PE Ratio is now.
What was Indaptus Therapeutics earnings per share over the trailing 12 months (TTM)?
Indaptus Therapeutics EPS is -3.56 USD over the trailing 12 months.
Which sector does the Indaptus Therapeutics company belong to?
The Indaptus Therapeutics sector is Healthcare.
Indaptus Therapeutics INDP included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26333.04 USD — |
+0.96
|
5.66B USD — | 26283.11 USD — | 26431.22 USD — | — - | 5.66B USD — |
|
US Tech Health Care
IXHC
US
|
1293.65 USD — |
+0.08
|
— — | 1293.64 USD — | 1310.12 USD — | — - | — — |
- {{ link.label }} {{link}}
